Diagnostic workflow for X‐linked agammaglobulinemia integrating BTK expression and B‐cell maturation analysis by flow cytometry

2026

Closed access Metadata (CSL-JSON)
DOI 10.1002/cyto.b.70038
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

X-linked agammaglobulinemia (XLA) is most often caused by impaired Bruton's tyrosine kinase (BTK) function. Rapid laboratory support is needed when genetic findings are inconclusive or pending. We developed a flow-cytometric assay to quantify intracellular BTK protein in monocytes, aiding the diagnosis of XLA. A stain index (SI) reference range was established using healthy donors (n = 25; SI median 1.14, range 1.01-1.66). ROC analysis defined a diagnostic cutoff of SI = 1.79, providing 95% sensitivity and 100% specificity compared to patients with pathogenic BTK variants (n = 40). Using this cutoff, abnormal BTK expression was detected in 38/40 genetically confirmed XLA patients. All patients with variants of uncertain/likely pathogenic significance (n = 17) had SI values above the cutoff. Bone marrow analysis in a patient subset showed a developmental arrest at the Pre-BI stage. The assay offers a rapid, clinically applicable readout to support XLA diagnosis and carrier evaluation in females, effectively complementing genetic testing.